EN
Instrument Fundamentals
| Date | Close | Change | Change (%) | Open | High | Low |
|---|
News
Executives of the Year: Dennis Hancock
Pfizer Refocuses Growth Strategy as New Products Offset COVID Decline
Pfizer Invites Public to View and Listen to Webcast of November 3 Conference Call with Analysts
Drugs racket kingpin's pharmacy stayed open after raid, health officer suspended
How Investors Are Reacting To Pfizer (PFE) Easing Policy Pressures And New HHS Revenue-Sharing Deal
Spurious Drugs: Karnataka FDA Cancels 16 Drug Licences of Retailers, Wholesalers
Pfizer (NYSE:PFE) & Lyra Therapeutics (OTCMKTS:LYRA) Critical Survey
A consensus-based guideline for personalized bacteriophage therapy
Pfizer Says Its Biggest Headwinds Are Finally Easing. Does That Change the Story for This Ultra-High-Yield Dividend Stock?
Pfizer to share portion of increased revenue to U.S. HHS, Bloomberg says
Karnataka busts fake drug racket, suspends license of Pfizer depot, 7 other firms
FDA cancels 16, suspends eight drug licences in Karnataka | India News
Fake drugs: Karnataka cancels 16 licenses, suspends 8 including that of Pfizer depot
Pfizer Inc. (NYSE:PFE) Receives Consensus Recommendation of "Hold" from Brokerages
Pfizer to share higher overseas drug revenue with US health agency
Pancreatic Endocrine Tumor Market Outlook 2034: Growth Trends, Competitive Landscape, and Future Opportunities - DelveInsight | ABNewswire
Pfizer to Share Revenue With HHS in Deal on Overseas Drug Prices
Pfizer (PFE) versus Its Competitors Head to Head Contrast - Stock Observer
2 High-Yield Dividend Stocks to Buy and 1 to Avoid
US Treasury Department drafts rules to keep most pharma licensing deals with China alive
Pfizer's Dividend Yield Is Enormous. But Is the Payout Still Growing?
Exclusive-US weighs allowing most pharma licensing deals with China, sources say
Việt Nam promotes domestic capacity in vaccine technology
The exposome and inflammatory bowel disease: a framework for primary and primordial prevention
Did Trump lower Medicaid drug prices, as promised? : NPR
Pfizer's Dividend Faces Big Questions. Here Are 3 Reasons It Should Survive.
Alopecia Areata Market Poised for Growth Through 2036, Driven by Rising Diagnosis Rates and Breakthrough Targeted Therapies | Valuespectrum.com
Pfizer Raises 2026 Revenue Guidance to $62 Billion. Here's What's Behind the Beat
Is Pfizer's New Business Big Enough To Carry The Old One?
The Zacks Analyst Blog Highlights Pfizer, Novartis, Candel and Janux
John Dorfman: CEOs buy shares at Pfizer, Uber
What Is Pfizer (PFE) Really Getting From Its New ADC Licensing Deal?
Pfizer (PFE), Valneva (VALN) Lyme Vaccine Moves to EMA Review Despite Phase 3 Caveat
AstraZeneca's Oncology Engine Faces a Key Test After Camizestrant Miss
Klearcom announces two major appointments as Waterford firm looks to continue global expansion
IP Group H1 Earnings Call Highlights - Markets Daily
Bank of America Corp DE Buys New Stake in Pfizer Inc. $PFE
The Global Expansion Narrative of Chinese Innovative Drugs: A Game-Changing Development Set to Unfold in Two Weeks
Pfizer (NYSE:PFE) Stock Rating Upgraded by Wall Street Zen - Markets Daily
Pfizer Share Price Today 15 Sep 2026: Live NSE/BSE Rates, Technical Analysis and Expert Forecasts
Why Is Pfizer Stock Paying You So Much To Wait?
AZN's Etcamah Fails Late-Stage Study for First-line Breast Cancer
Pfizer Says Major Headwinds Are Easing as Pipeline, Obesity Plans Take Center Stage
AstraZeneca Breast-Cancer Drug Misses Goal in Late-Stage Trial | World News
4 High-Yield Dividend Stocks Worth Having in Your Roth IRA
Pfizer's 6% Yield Masks a Fragile Dividend Story
Top Pharmaceutical Stocks To Research - September 14th - Daily Political
Dow Jones Top Company Headlines at 11 PM ET: Amazon Pauses Operations With 21 Air After Miami Crash | Pfizer ... | Morningstar
Dow Jones Top Company Headlines at 9 PM ET: Amazon Pauses Operations With 21 Air After Miami Crash | Pfizer ... | Morningstar
Targeting CD38 with bispecific antibody XmAb 18968 in patients with relapsed/refractory acute myeloid leukemia and T-cell acute lymphoblastic leukemia
Pfizer (NYSE:PFE) Upgraded to Buy at Wall Street Zen - Daily Political
Pharmaceutical Stocks To Keep An Eye On - September 13th - Daily Political
Pfizer (NYSE:PFE) Rating Increased to Buy at Wall Street Zen
Clinical usability of an explainable AI decision support tool and evaluation of multimodal models in NSCLC
Medicus Pharma CEO on SkinJect and Pfizer partnership - ICYMI
The Manufacturers Life Insurance Company Lowers Stock Holdings in Pfizer Inc. $PFE
WINTON GROUP Ltd Purchases New Holdings in Pfizer Inc. $PFE - Stock Observer
The 10-Year Treasury Pays Nearly 5% These 6 Dividend Stocks Still Pay More
Former FDA Chief Gottlieb Trashed COVID-19 Seroprevalence Studies, Memo Reveals - NaturalNews.com
Integrated Wealth Concepts LLC Has $11.05 Million Position in Pfizer Inc. $PFE - Daily Political
Novavax Highlights Sanofi, Pfizer Catalysts in Matrix-M Platform Pivot
Pfizer Stock Or Zoetis: Is The Comeback Worth Paying Up For?
Tidal Investments LLC Has $47.48 Million Stock Holdings in Pfizer Inc. $PFE
Waverly Advisors LLC Has $12.80 Million Stock Holdings in Pfizer Inc. $PFE - Markets Daily
Pfizer (PFE) versus Its Peers Financial Review - Stock Observer
Novartis India zooms 51% in 3 days; what's driving the pharma stock? | Markets News - Business Standard
Pfizer Inc. $PFE Shares Bought by Waverly Advisors LLC - Stock Observer
Eosinophilic Esophagitis Market: Rapid Increment Driven by Innovation by 2036 - DelveInsight | Regeneron, Sanofi, Bristol-Myers Squibb, Ellodi Pharma, AstraZeneca, Allakos, EsoCap AG, Pfizer, Ception | ABNewswire
Type 2 Diabetes Market Growth Outlook 2036: Epidemiology, Pipeline Therapies, and Revenue Forecast - DelveInsight | Eli Lilly, Regor Pharma, AstraZeneca, Eccogene, Pfizer, Sciwind Biosciences | ABNewswire
Sickle Cell Disease Clinical Trial Pipeline: Emerging Therapies and Key Developments Shaping the Treatment Landscape | DelveInsight | ABNewswire
Metastatic Hormone Refractory Prostate Cancer Clinical Trial Pipeline Appears Robust With 180+ Key Pharma Companies Actively Working in the Therapeutics Segment | DelveInsight | ABNewswire
Jim Cramer Picks J&J (JNJ) Over Eli Lilly (LLY) and Pfizer (PFE) Among These Healthcare Stocks
Deals/M&As: Medicus takes on Pfizer's ADC; Abbvie-Apogee M&A closes
Novartis-Pfizer trademark deal has opposite impact on their stock prices; Novartis India jumps 20% while Pfizer slips 3%
Allworth Financial LP Cuts Stake in Pfizer Inc. $PFE
Novartis India shares zoom 20% to hit record high; Minipress deal fuels rally
RBC Capital downgrades GlaxoSmithKline (GSK) to a Hold
RBC Capital Reaffirms Their Buy Rating on AstraZeneca (AZN)
Myeloperoxidase inhibition with mitiperstat in heart failure with preserved or mildly reduced ejection fraction: a randomized phase 2b trial
RBC Capital Initiates a Hold Rating on Sanofi (SNYNF)
Pfizer (NYSE:PFE) Stock Price Down 2.4% - Here's What Happened
Pfizer (NYSE:PFE) Stock Price Down 2.4% - Should You Sell?
Why Pfizer Stock Was so Healthy in August
Volumes spurt at Pfizer Ltd counter
Cygnus Capital Advisors LLC Reduces Stock Holdings in Pfizer Inc. $PFE
Pfizer shares hit 52 week low after Minipress XL discontinuation; Novartis zooms 13% - BusinessToday
Novartis India Acquires Pfizer's Minipress Brand for ₹1250 Crore Amidst Pharma Challenges, ETPharma
Forget the Dividend. This Could Be the Real Reason to Buy Pfizer Stock Now
PFIZER News
Dollar to Mexican Peso Forecast 2026–2030: Can USD/MXN Break Above 17.50 as the Rate Gap Narrows?
Avalanche Price Prediction 2026–2030: Can Institutional Tokenization Push AVAX Back Above $10?
Advanced CFD Trading Tools Review: Which Tools Can Improve Your Trading Decisions?
Upcoming IPOs 2026: The Biggest Companies to Watch and Major Listings So Far
Latest news
Show more
EUR/USD Falls Below 1.1450 as Fed Policy and Weak Eurozone Confidence Weigh on Euro
Micron Stock Hits Record High as AI Memory Demand Fuels Q4 Earnings Optimism
Copper Price Hits a Record $6.83 as AI Demand and Supply Shortages Fuel the Rally
GBP/USD Falls Below 200-Day Average as Fed–BoE Divergence Pressures Sterling
WTI Crude Slips Below $90 as Falling Energy Costs Ease Inflation Pressure
